Ana Suarez-Valle, Borja Diaz-Guimaraens, Miguel Dominguez-Santas, Diego Fernandez-Nieto, David Saceda-Corralo
No abstract text available.
Biswas B, Ghadyalpatil N, Krishna MV, Deshmukh J. A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients. Indian J Cancer. 2017;54:S55-S64. https://doi.org/10.4103/ijc.IJC_589_17.
Toda N, Fujimoto N, Kato T, et al. Erosive pustular dermatosis of the scalp-like eruption due to gefitinib: case report and review of the literature of alopecia associated with EGFR inhibitors. Dermatology. 2012;225(1):18-21. https://doi.org/10.1159/000341528.
Kremer N, Martinez H, Leshem YA, et al. The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: a case series. JAAD. 2020. https://doi.org/10.1016/j.jaad.2020.03.055.
Karanfilian KM, Wassef C. Erosive pustular dermatosis of the scalp: causes and treatments. Int J Dermatol. 2020. https://doi.org/10.1111/ijd.14955.
Wu C-Y, Chen G-S, Lan C-CE. Erosive pustular dermatosis of the scalp after gefitinib and radiotherapy for brain metastases secondary to lung cancer. Clin Exp Dermatol. 2008;33(1):106-107. https://doi.org/10.1111/j.1365-2230.2007.02566.
Skellett AM, Levell NJ. Erosive pustular dermatosis and osteoradionecrosis: complications of radiotherapy. Clin Exp Dermatol. 2011;36(1):98-99. https://doi.org/10.1111/j.1365-2230.2010.03887.x.
Maglie R, Antiga E. Nivolumab-induced erosive pustular dermatosis of the scalp. Int J Dermatol. 2020. https://doi.org/10.1111/ijd.14990.
